department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

DECITABINE · pharmadog

pharmadog
drugs
DECITABINE

drug

patient view →

DECITABINE

Marketedupdated 2mo ago

by Mylan Institutional Inc

Approved

community read0 votes

Small molecule drug with a maximum clinical stage of Approval (across all indications), with 6 approved and 34 investigational indications.

all catalysts(1)

approval · 1

DECITABINE — FDA approval

News(0)

no news has mentioned this drug yet

brand

DECITABINE

generic

DECITABINE

MOA

DNA (cytosine-5)-methyltransferase 1 inhibitor; DNA (cytosine-5)-methyltransferase 3A inhibitor

indication

Chronic Myelomonocytic Leukemia (CMML)

phase

marketed

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

openFDA · ClinicalTrials.gov

last refreshed 2h ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

🐶 often sniffed alongside

top 3

tagApproval2 co-mentions · 1 sources
drug(decitabine + tetrahydrouridine)1 co-mentions · 1 sources
drugCHA-0011 co-mentions · 1 sources

Trials studying DECITABINE

phase2Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Caactive not recruitingn=46
phase2Venetoclax in Combination With ASTX727 for the Treatment of Treatment-Naive High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemiaactive not recruitingn=52
phase1Entrectinib in Combination With ASTX727 for the Treatment of Relapsed/Refractory TP53 Mutated Acute Myeloid Leukemiaactive not recruitingn=13
phase1A Phase I Study of Decitabine, Lisaftoclax, and Olverembatinib in Patients With Advanced Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Myeloid Leukemiarecruitingn=30
phase2Research for Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-MDS) in the Treatment of Myelodysplastic Syndrome (MDS)suspendedn=40
phase1Study of Pembrolizumab Combined With Decitabine and Pralatrexate in PTCL and CTCLactive not recruitingn=37
phase1Axatilimab Combined With Decitabine/Venetoclax for the Treatment of TP53-mutated AMLnot yet recruitingn=32
phase1Avapritinib With Decitabine in Patients With SM-AHNrecruitingn=34

more trials →